Immune Design Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
48.16 M |
Public Float |
35.18 M |
Immune Design Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.38 |
Market Cap |
$163.76 M |
Shares Outstanding |
48.17 M |
Public Float |
28.99 M |
Address |
1616 Eastlake Avenue East Seattle Washington 98102 United States |
Employees | - |
Website | http://www.immunedesign.com |
Updated | 09/14/2018 |
Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. |